Skip to main content
. Author manuscript; available in PMC: 2013 Nov 18.
Published in final edited form as: Cancer Causes Control. 2013 Feb 15;24(5):10.1007/s10552-013-0170-8. doi: 10.1007/s10552-013-0170-8

Table 1.

Selected characteristics of population-based controls according to categories of tea and coffee consumption, King County, Washington, 2002-2005

Categories of consumption (cups/unit of time)
Tea ≤1/week 2-6/week 1/day ≥2/day

 Controls, No. 594 109 69 91
 Mean age, y (SD) 61.2 (8.4) 59.3 (7.1) 63.8 (6.9) 63.5 (7.3)
 Caucasian, % 90.7 85.3 92.8 92.3
 First-degree family history of prostate cancer, % 12.3 11.9 7.2 9.9
 College or graduate degree, % 56.4 62.4 65.2 65.9
 Mean BMI, kg/m2 (SD) 27.9 (4.6) 27.5 (4.1) 26.5 (4.8) 27.1 (4.8)
 Never smoker, % 44.8 40.4 56.5 57.1
 Aspirin use*, % 51.3 53.2 53.6 53.8
 Non-aspirin NSAID use*, % 20.9 23.9 13.0 16.5
 Diabetes mellitus, % 10.4 11.9 10.1 9.9
 History of PSA testing, % 58.2 52.3 60.9 71.4
 ≥2 cups of coffee per day, % 46.5 35.5 32.4 24.2

Coffee ≤1/week 2-6/week 1/day 2-3/day ≥4/day

 Controls, No. 257 100 146 253 104
 Mean age, y (SD) 60.3 (8.5) 60.9 (7.8) 62.1 (8.5) 62.0 (7.8) 61.4 (7.2)
 Caucasian, % 86.8 81.0 90.4 95.3 96.2
 First-degree family history of prostate cancer, % 11.7 10.0 11.0 13.0 10.6
 College or graduate degree, % 60.3 56.0 61.0 62.5 46.2
 Mean BMI, kg/m2 (SD) 27.6 (5.2) 28.2 (4.6) 27.2 (4.1) 27.6 (4.1) 27.8 (4.5)
 Never smoker, % 62.3 56.0 50.0 36.4 17.3
 Aspirin use*, % 47.9 51.0 52.1 53.0 60.6
 Non-aspirin NSAID use*, % 21.0 17.0 17.8 21.3 21.4
 Diabetes mellitus, % 9.7 10.0 9.6 12.6 9.6
 History of PSA testing, % 55.3 51.0 67.1 61.7 57.7
 ≥1 cup of tea per day, % 28.9 8.1 22.6 15.8 3.8

Abbreviations: SD, standard deviation; NSAID, non-steroidal anti-inflammatory drug; PSA, prostate-specific antigen.

*

Use at least once a week for 3 months or longer.

PSA testing within the 5-year period before reference date.